enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Endo International - Wikipedia

    en.wikipedia.org/wiki/Endo_International

    Endo is one of the companies named in lawsuits by the states of Ohio, [42] Missouri and Mississippi [43] as responsible for the US opioid epidemic. Its 10-K statement indicates that a majority of the company's US revenue in 2016 was derived from the sale of prescription pain killers, predominantly opioids .

  3. List of Schedule II controlled substances (U.S.) - Wikipedia

    en.wikipedia.org/wiki/List_of_Schedule_II...

    opiate Codeine [2] 9334 opiate Dihydroetorphine [3] 9190 opiate Ethylmorphine [2] 9059 opiate Etorphine hydrochloride [4] 9640 opiate Granulated opium [2] 9193 opiate Hydrocodone [2] 9150 opiate Hydromorphone [2] 9260 opiate Metopon [2] 9300 opiate Morphine [2] 9668 opiate Noroxymorphone [5] 9610 opiate Opium extracts [2] 9620 opiate Opium ...

  4. Titan Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Titan_Pharmaceuticals

    Titan's principal asset is Probuphine, [5] [6] a slow-release implant formulation of buprenorphine [7] for the treatment of opioid addiction or chronic pain. FDA Approval was granted on 26 May 2016. [8] It was licensed to Braeburn Pharmaceuticals for marketing and commercialization. [6]

  5. Tennessee regulations prevent good addiction treatment for ...

    www.aol.com/tennessee-regulations-prevent-good...

    The law (TN Code 53-11-311) that prevents nurse practitioners (NPs) or physician assistants (PAs) from prescribing more than 16 milligrams of buprenorphine-naloxone daily (despite standard dosing ...

  6. DOJ files complaint against CVS for facilitating unlawful ...

    lite.aol.com/pf/story/0001/20241218/b402388119be...

    The filing of the complaint follows the announcement on Friday that the McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive drug OxyContin.

  7. McKinsey & Company agrees to pay $650M for helping ... - AOL

    www.aol.com/mckinsey-company-agrees-pay-650...

    McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive ...

  8. Consulting firm McKinsey to pay $650 million to resolve US ...

    www.aol.com/consulting-firm-mckinsey-pay-650...

    McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

  9. Emergent BioSolutions - Wikipedia

    en.wikipedia.org/wiki/Emergent_BioSolutions

    Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. [2] It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.